OKYO
OKYO Pharma Ltd
1.30$
+3.9%
vs. previous close
Closing price · As of: Oct 1, 2026
Statements
Cash Flow
OKYO Pharma Ltd (OKYO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2026), "Operating Cash Flow" came in at -5.9 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.5 | -0.2 | -0.9 | -1.3 | -4.7 | -3.8 | -3.5 | -1.4 | -0.7 | -0.7 | -1.6 | -2.0 | -1.2 | -1.6 | -5.5 | -7.7 | -9.5 | -1.8 | -5.9 | |
| – | – | – | – | 0.0 | 0.0 | 0.1 | – | – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 2.4 | 0.1 | 0.2 | 0.2 | 0.8 | 1.3 | 1.4 | 0.2 | 0.1 | 0.0 | 0.0 | 0.1 | 0.0 | 0.5 | 1.7 | 1.3 | 1.1 | 0.7 | 1.6 | |
| – | – | – | – | – | – | – | – | – | – | 19 | 2.1 | 0.1 | 0.9 | 0.7 | – | – | – | – | |
| 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | -0.4 | -0.1 | -0.1 | 0.1 | -0.4 | 0.0 | 0.2 | 0.2 | 1.0 | -1.0 | 3.9 | 2.7 | 1.6 | -0.6 | |
| 2.8 | 0.7 | 0.0 | 0.0 | 3.5 | 7.2 | 11 | 2.8 | 0.4 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| -2.8 | -11 | 21 | 29 | -4.1 | -7.2 | -11 | -2.8 | -0.3 | -0.4 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | – | 0.0 | -6.0 | |
| – | – | – | 41 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.0 | 5.9 | 0.0 | 2.0 | 0.0 | 1.0 | 0.0 | |
| 21 | 3.9 | 1.0 | -40 | 9.3 | 8.7 | 10 | 0.4 | 0.0 | 0.0 | 0.8 | 0.8 | 1.0 | 7.8 | 2.2 | 9.3 | 6.2 | 2.7 | 25 | |
| 18 | -7.6 | 21 | -12 | 1.0 | -1.8 | -3.9 | -4.1 | -1.1 | -0.7 | -1.6 | -2.0 | -0.4 | 6.7 | -4.2 | 1.3 | -3.2 | 0.7 | 13 | |
| -3.3 | -0.9 | -0.9 | -1.3 | -8.2 | -11 | -14 | -4.2 | -1.1 | -1.0 | -1.6 | -2.0 | -1.2 | -1.6 | -5.5 | -7.7 | -9.5 | -1.8 | -5.9 |
Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.